Filling the need for trusted information on national health issues…

GSK, Crucell To Test Second-Generation Malaria Vaccine

GlaxoSmithKline and drug company Crucell, a division of Johnson & Johnson, will collaborate with the PATH Malaria Vaccine Initiative to test a second-generation malaria vaccine “within the next couple of months,” Reuters reports. “GSK’s first-generation vaccine, known as RTS,S or Mosquirix, is in late-stage development and could reach the market in 2015. … The new vaccine is an amended version of the current GSK shot that adds an engineered common cold virus developed by Crucell to ‘prime’ the immune system to get a stronger response,” the news service writes (Hirschler, 6/6).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.